InflaRx Reports Preclinical Kidney Data for Izicopan
InflaRx reported that izicopan inhibited C5aR-mediated inflammation and reduced kidney injury in hamster IRI and UUO models.
InflaRx reported that izicopan inhibited C5aR-mediated inflammation and reduced kidney injury in hamster IRI and UUO models.